Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Show more...
首席执行官
Mr. Kevin Strange
员工
1300
国家
US
ISIN
US45332Y1091
上市
0 Comments
分享你的想法
FAQ
Inari Medical 今天的股价是多少?▼
NARI 当前价格为 $79.97 USD,过去 24 小时上涨了 +0.05%。在图表上更密切关注 Inari Medical 股价表现。
Inari Medical 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Inari Medical 的股票以代码 NARI 进行交易。